Large-scale testing (Phase 3)Study completedNCT01572792
What this trial is testing
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 921